Cutting Edge: Virus-Specific CD8 + T Cell Clones and the Maintenance of Replicative Function during a Persistent Viral Infection Oliver Bannard, Matthew Kraman, and Douglas T. Fearon Persistent viral infections induce the differentiation and accumulation of large numbers of senescent CD8 + T cells, raising the possibility that repetitive stimulation drives clones of T cells to senesce. It is therefore unclear whether T cell responses are maintained by the selfrenewal of Ag-experienced peripheral T cell subsets or by the continuous recruitment of newly generated naive T cells during chronic infections. Using a transgenic mouse model that permits the indelible marking of granzyme B-expressing cells, we found that T cells primed during the initial stages of a persistent murine g-herpes infection persisted and continued to divide during a latent phase of up to 7 mo. Such cells maintained an ability to extensively replicate in response to challenge with influenza virus expressing the same Ag. Therefore, Agexperienced, virus-specific CD8 + T cell populations contain a subset that maintains replicative potential, despite long-term, persistent antigenic stimulation. The Journal of Immunology, 2010, 185: 7141-7145. P ersistent viral infections represent an important challenge to the immune system. When such viruses enter a state of latency, sporadic viral reactivation means that constant immune surveillance by CD8 + T cells is required and that virus-specific lymphocytes may be repetitively stimulated. Studies assessing the cellular incorporation of deuterated glucose in humans (1) , and BrdU in mice (2) , have shown continual Ag-dependent division of CD8 + T cells throughout the persistent stage of infection. Only two possible mechanisms may account for the maintenance of these CD8 + T cell responses: either a population of Ag-experienced lymphocytes retains the capacity for Ag-driven self-renewal or new thymic emigrants are recruited to the antiviral response as pre-existing clones are lost through a process of replicative senescence.
Support for models in which the recruitment of new thymic emigrants is required for the maintenance of CD8 + T cell responses comes from the observations that senescent KLRG-1 + CD8 + T cells accumulate during persistent infections (3) , that adoptively transferred T cells lose replicative capacity when subjected to repetitive antigenic stimulation (4) , that virus-specific, donor CD8 + T cells do not contribute to the long-term antiviral immune response of recipient, persistently infected mice (5, 6) , and that anti-polyoma-specific T cell responses are impaired in thymectomized mice (5) . However, evidence from experiments using partial bone marrow chimeric mice indicated that a subset, or subsets, of peripheral activated T cells retain a capability for continuous Ag-driven self-renewal during murine cytomegalovirus infection, and other studies have failed to detect any significant impairment of the T cell response as a consequence of surgical removal of the thymus (6, 7) . Therefore, it is unclear as to which of these mechanisms represents the principle means by which immunity is maintained throughout long-term infections.
We previously reported the generation of the gzmBCreER T2 / ROSA26EYFP transgenic (tg) mouse line, which permits the conditional and indelible marking with enhanced yellow fluorescent protein (EYFP) of CD8 + T cells expressing granzyme B (gzmB) in vivo, by the administration of tamoxifen (Fig. 1A ) (8) . This model permits for fate mapping of clones of T cells without the need for invasive interventions such as adoptive transfer. In this study, we have used these tg mice to evaluate the persistence and replication of Ag-specific CD8 + T cell clones during infection with murine g-herpes virus-68 (MHV-68), a natural rodent pathogen that establishes life-long latency in lymphocytes (9) .
Materials and Methods
GzmBCreERT2/ROSA26EYFP mice were infected intranasally with 2 3 10 4 PFU MHV-68-M3-OVA or with 3 3 10 4 PFU influenza virus (WSN-OVA) following isoflurane anesthesia (9, 10) . Mice received daily injections of tamoxifen (10 mg) via i.p. injection. BrdU (Sigma-Aldrich, St. Louis, MO) was administered either by i.p. injection (2 mg every 12 h) or by dissolving it in the animals' drinking water at 0.8 mg/ml with 1% glucose.
Single-cell suspensions were counted by flow cytometry (Caltag counting beads, Invitrogen, Carlsbad, CA). Dead cell discrimination was performed using either 7-aminoactinomycin D or Live/Dead Aqua stain (Invitrogen). Cells were stained with MHC-peptide dextramers (H-2kb/SIINFEKL, Immudex, Copenhagen, Denmark). All Abs for were purchased from eBioscience (San Diego, CA), except for the mouse anti-BrdU Ab. Intracellular staining for BrdU was performed with the BrdU Flow Kit (BD Pharmingen, San Diego, CA). For some experiments, an anti-BrdU Ab was labeled with Pacific Blue (Invitrogen Ab labeling kit). Analysis was performed on BD FACSCalibur (BD Biosciences, San Jose, CA) and DakoCytomation Cyan flow cytometers Wellcome Trust Immunology Unit, University of Cambridge, Cambridge, United Kingdom (DakoCytomation, Carpinteria, CA) and using FlowJo software (Tree Star, Ashland, OR).
Results and Discussion

Clones of virus-specific CD8 + T cells persist during persistent murine g-herpes infections
To determine whether clones of activated virus-specific T cells persist during a chronic viral infection, a cohort of tg mice was infected with a modified MHV-68 that expresses OVA under the control of the lytic M3 promotor (9) . gzmB-expressing CD8 + T cells were indelibly marked as EYFP + by the administration of tamoxifen on days 4-11 postinfection (p.i.) (Fig. 1A) . We characterized the OVA-specific CD8 + T cell response by enumerating multimer-binding CD8 + T cells in the spleen at various times p.i. Following a peak in the number of multimer-binding cells on day 14 p.i., there was a period of contraction after which the number of OVA-specific CD8 + T cells remained relatively constant during 7 mo of observation (Fig. 1B) . A similar pattern was reported for several endogenous MHV-68 epitopes (11) .
The measurement of EYFP expression by OVA-specific CD8 + T cells permitted an analysis of the relative persistence of activated CD8 + T cell clones during the chronic phase of infection. At the peak of the response on day 14 p.i., 22% of multimer-binding splenic CD8 + T cells were EYFP + (Fig. 1C) . The inability to mark 100% of gzmB-expressing CD8 + T cells as EYFP + using this model system probably relates to inefficient recombination by the CreERT2 fusion protein (8) . By day 64 p.i., the proportion of OVA-specific CD8 + T cells that were EYFP + had decreased to 9%, indicating either that a subset of gzmB-expressing cells had died during the contraction phase or that EYFP 2 CD8 + T cells were proliferating at a faster rate during latency. Following this initial reduction, the frequency of multimer-binding cells that were EYFP + remained relatively steady for the remainder of the experimental period, which indicated that a stable population of OVA-specific CD8 + T cell clones may be generated during the early phase of infection with MHV-OVA.
A commitment to senescence with attendant loss might be anticipated to occur late during the acute phase of infection when virus-specific CD8 + T cells may be more likely to be differentiating to terminal effector cells. We therefore assessed the relative reductions in the proportion EYFP + , OVA-specific CD8 + T cells during the contraction phase when clones were marked by administration of tamoxifen to tg mice early (days 1-5) or late (days 4-11) during the acute, priming phase of MHV-OVA infection. The proportion of EYFP + OVA-specific CD8 + T cells in the blood was assessed on days 14 p.i. and 39 p.i. (Fig. 1D) , revealing equivalent decreases of 44 and 47%, respectively, in the proportion of cells that were EYFP + in mice treated early and late with tamoxifen. Therefore, if this reduction in CD8 + T cells that had expressed gzmB was a consequence of preferential senescence or death, then the commitment to this fate had already occurred by day 5 p.i. The previous finding of a correlation between magnitude of gzmB expression and EYFP frequency also raises the possibility that the highest gzmB-expressing cells may be preferentially lost during this period of contraction (8) .
Clones of CD8
+ T cells retain proliferative KLRG-1-ve subsets during persistent MHV infection KLRG-1 + T cells accumulate during persistent g-herpes infections (3) and after repetitive acute infections (4). We therefore assessed whether CD8 + T cells derived from clones that had been activated many weeks earlier may preferentially acquire this senescent phenotype. We assessed EYFP + , OVA-specific, and total OVA-specific splenic CD8 + T cell populations from MHV-OVA-infected mice that were treated with tamoxifen on days 4-11 p.i. for expression of KLRG-1 on days 14, 60, 105, and 210 p.i. The proportions of EYFP + and total OVA-specific CD8 + T cells expressing KLRG-1 were not significantly different at any of the time points assessed (p . 0.22) (Fig. 2A) . Moreover, the proportion of EYFP and total OVA-specific CD8 + T cells that were KLRG-1 + actually decreased with time p.i., probably FIGURE 1. gzmB expression marks clones of CD8 + T cells that persist during a long-term murine g-herpes infection. GzmBCreERT2 BAC transgenic mice were crossed to the ROSA26EYFP line. gzmB expression in the presence of tamoxifen leads to CreERT2 mediated excision of the loxP flanked stop codon and permanent expression of EYFP (A). tg mice were infected with MHV-OVA and treated with tamoxifen on days 4-11 p.i. Splenic OVAspecific CD8 + T cells were enumerated over time (B), and the proportion of OVA-specific CD8 + T cells that were EYFP + was assessed (C). tg mice were infected with MHV-OVA and treated with tamoxifen either on days 1-5 p.i. reflecting the preferential cell death of terminally differentiated cells as the lytic infection is controlled. These findings suggest that repetitive antigenic stimulation does not induce all members of a clonal CD8 + T cell population to acquire the KLRG-1 + terminally differentiated phenotype during this persistent viral infection.
We further assessed virus-specific cells primed early in the immune for signs of senescence by comparing the rate of turn- over of EYFP + , OVA-specific, and total OVA-specific splenic CD8 + T cells. Mice were provided with BrdU-containing water for 10 d periods prior to analysis on days 60, 105, and 210 p.i. EYFP + OVA-specific CD8 + T cells incorporated BrdU at all three time points, and the EYFP + and total Ag-specific populations were equivalent in terms of the frequency of BrdU + cells (p . 0.27) (Fig. 2B ). In keeping with previous reports, the proportion of MHV-68-specific CD8 + T cells that were BrdU + decreased with time, from ∼35% on day 60 p.i to just 11.7% when analyzed on day 210 p.i (2), probably reflecting a decrease in the availability of Ag and pro-proliferative cytokines during latency. KLRG-1 + CD8 + T cells are capable of some cellular division during acute lymphocytic choriomeningitis virus infection, but they do not persist into the memory phase once the virus has been cleared (12) . When we costained splenic EYFP + OVAspecific CD8 + T cells from MHV-OVA-infected mice on day 60 p.i., we found that that a greater proportion of KRLG-1 + than KLRG-1 2 cells were BrdU + (Fig. 2C) . The increased BrdU incorporation by KRLG1 + cells, taken together with the finding that the KLRG-1 + proportion of EYFP and total OVAspecific CD8 + T cells does not increase with time during the latent phase of infection (Fig. 2B) , indicates that KLRG-1 + cells may be both proliferating and dying faster than KLRG-1 2 cells or that CD8
+ T cells become KLRG-1 + as they proliferate.
In summary, clones of activated virus-specific CD8 + T cells persist, retain a presenescent replicative subset, and continue to divide for .7 mo during a chronic murine g-herpes infection.
Virus-specific CD8 + T cells retain the capacity for extensive clonal expansion
The finding of equal KRLG-1 expression ( Fig. 2A) and BrdU incorporation (Fig. 2B) by EYFP + and total OVA-specific CD8 + T cells suggested no replicative disadvantage for T cell clones that were recruited early in the infection, as compared with a population that may have included new thymic emigrants recruited during the latent phase. However, these findings do not exclude the possibility that these long-term persistent CD8 + T cell clones may be relatively impaired in their capacity for possible rapid and extensive replication in response to a new challenge with a rapidly replicating virus expressing the same Ag. This situation is analogous to a period of extensive viral reactivation.
The tg mice were infected with MHV-OVA and treated with tamoxifen on days 4-11 p.i. One-hundred-twenty days later, the same mice were reinfected via the intranasal route with a recombinant strain of influenza virus that that expresses the SIINFEKL epitope in its neuramidase stalk (WSN-OVA) (10) , and the OVA-specific CD8 + T cell response was examined. By day 7 post influenza-OVA infection, there was a .100-fold increase in the number of OVA-specific CD8 + T cells in the lungs and a .10-fold increase in the draining mediastinal lymph nodes (Fig. 3A) . The increase in number of OVAspecific cells in the lungs after influenza infection was most likely caused by Ag-dependent clonal expansion because there was a selective enrichment for this specificity (Fig. 3B) , and almost all multimer-binding cells were found to have incorporated BrdU when administered during the secondary challenge (Fig. 3C) .
We compared the frequency of EYFP + OVA-specific CD8 + T cells in the blood before influenza-OVA infection and in the lungs on day 7 p.i. for each mouse. Despite extensive proliferation, there was no change in the frequency of OVAspecific CD8 + T cells that were EYFP + , indicating that CD8 + T cells that had been marked as EYFP + on days 4-11 post MHV-OVA infection replicated as well as all OVA-specific CD8 + T cells when mice were challenged with influenza-OVA 120 d later.
Our findings support a model in which the anti-MHV-68 CD8 + T cell response is maintained principally by the continuous turnover of a subset, or subsets, of activated T cells that had been primed during the initial stage of the infection. Although more differentiated subsets of cells, such as those which are KLRG-1 + , appear capable of some limited short-term proliferation, their long-term persistence probably requires that they be replaced through division and subsequent differentiation of a precursor subset in the secondary lymphoid tissues. The local expression at sites of infection of IL-15, possibly in response to type I IFN, may provide a means by which the innate immune response is able to regulate the numbers of KLRG-1 + cells in the tissue (12, 13) . Peripheral KLRG-1 + T cell populations provide an immediate barrier to reactivation/ reinfection and possibly also act to amplify local responses during reactivation via rapid expression of chemokines, such as CCL3, CCL4, and RANTES (14, 15) . Our findings do not exclude a role for new thymic emigrants in maintaining responses, but they do indicate that their development and recruitment to the response is not required for the continued generation of new effectors.
